These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1164 related items for PubMed ID: 29166338

  • 1. Use of Organs From Hepatitis C Virus-Positive Donors for Uninfected Recipients: A Potential Cost-Effective Approach to Save Lives?
    Trotter PB, Summers DM, Ushiro-Lumb I, Robb M, Bradley JA, Powell J, Watson CJE, Neuberger J.
    Transplantation; 2018 Apr; 102(4):664-672. PubMed ID: 29166338
    [Abstract] [Full Text] [Related]

  • 2. Cost-effectiveness of hepatitis C-positive donor kidney transplantation for hepatitis C-negative recipients with concomitant direct-acting antiviral therapy.
    Gupta G, Zhang Y, Carroll NV, Sterling RK.
    Am J Transplant; 2018 Oct; 18(10):2496-2505. PubMed ID: 30075489
    [Abstract] [Full Text] [Related]

  • 3. Liver Transplant From Increased-Risk Donors in the Era of Direct-Acting Antivirals for Hepatitis C.
    Shaikh OS, Rogal S, Malik A, Sharma V, Cacciarelli T.
    Exp Clin Transplant; 2020 Oct; 18(5):605-611. PubMed ID: 31324136
    [Abstract] [Full Text] [Related]

  • 4. Cost-effectiveness of using kidneys from hepatitis C nucleic acid test-positive donors for transplantation in hepatitis C-negative recipients.
    Kadatz M, Klarenbach S, Gill J, Gill JS.
    Am J Transplant; 2018 Oct; 18(10):2457-2464. PubMed ID: 29797402
    [Abstract] [Full Text] [Related]

  • 5. Cost-effectiveness of Using Kidneys From HCV-Viremic Donors for Transplantation Into HCV-Uninfected Recipients.
    Eckman MH, Woodle ES, Thakar CV, Alloway RR, Sherman KE.
    Am J Kidney Dis; 2020 Jun; 75(6):857-867. PubMed ID: 32081494
    [Abstract] [Full Text] [Related]

  • 6. Short-term outcomes of deceased donor renal transplants of HCV uninfected recipients from HCV seropositive nonviremic donors and viremic donors in the era of direct-acting antivirals.
    La Hoz RM, Sandıkçı B, Ariyamuthu VK, Tanriover B.
    Am J Transplant; 2019 Nov; 19(11):3058-3070. PubMed ID: 31207073
    [Abstract] [Full Text] [Related]

  • 7. The impact of direct-acting antiviral agents on liver and kidney transplant costs and outcomes.
    Axelrod DA, Schnitzler MA, Alhamad T, Gordon F, Bloom RD, Hess GP, Xiao H, Nazzal M, Segev DL, Dharnidharka VR, Naik AS, Lam NN, Ouseph R, Kasiske BL, Durand CM, Lentine KL.
    Am J Transplant; 2018 Oct; 18(10):2473-2482. PubMed ID: 29701909
    [Abstract] [Full Text] [Related]

  • 8. Successful heart-kidney transplantation from a Hepatitis C viremic donor to negative recipient: One year of follow-up.
    Wettersten N, Tran H, Mekeel K, Pretorius V, Adler E, Aslam S.
    Transpl Infect Dis; 2019 Feb; 21(1):e13002. PubMed ID: 30222242
    [Abstract] [Full Text] [Related]

  • 9. Changes in Utilization and Discard of HCV Antibody-Positive Deceased Donor Kidneys in the Era of Direct-Acting Antiviral Therapy.
    Bowring MG, Kucirka LM, Massie AB, Ishaque T, Bae S, Shaffer AA, Garonzik Wang J, Sulkowski M, Desai N, Segev DL, Durand CM.
    Transplantation; 2018 Dec; 102(12):2088-2095. PubMed ID: 29912046
    [Abstract] [Full Text] [Related]

  • 10. Current Use of Hearts From Hepatitis C Viremic Donors.
    Moayedi Y, Fan CPS, Gulamhusein AF, Manlhiot C, Ross HJ, Teuteberg JJ, Khush KK.
    Circ Heart Fail; 2018 Dec; 11(12):e005276. PubMed ID: 30562093
    [Abstract] [Full Text] [Related]

  • 11. Pros and Cons: Usage of organs from donors infected with hepatitis C virus - Revision in the direct-acting antiviral era.
    Coilly A, Samuel D.
    J Hepatol; 2016 Jan; 64(1):226-31. PubMed ID: 26375245
    [Abstract] [Full Text] [Related]

  • 12. Kidney Transplant Program at the Mayo Clinic in Arizona.
    Heilman RL, Khamash HA, Huskey JL, Chakkera HA, Batra RK, Katariya NN, Singer AL, Mathur AK, Moss AA, Reddy KS.
    Clin Transpl; 2014 Jan; ():61-8. PubMed ID: 26281128
    [Abstract] [Full Text] [Related]

  • 13. Liver Transplantation of HCV-viremic Donors Into HCV-negative Recipients in the United States: Increasing Frequency With Profound Geographic Variation.
    Cotter TG, Aronsohn A, Reddy KG, Charlton M.
    Transplantation; 2021 Jun 01; 105(6):1285-1290. PubMed ID: 32639400
    [Abstract] [Full Text] [Related]

  • 14. The UNOS Renal Transplant Registry: Review of the Last Decade.
    Andre M, Huang E, Everly M, Bunnapradist S.
    Clin Transpl; 2014 Jun 01; ():1-12. PubMed ID: 26281122
    [Abstract] [Full Text] [Related]

  • 15. Deceased Donor Kidney Transplantation in Taiwan in 2015.
    Lee PC, Chiang YJ, Chen ST.
    Clin Transpl; 2014 Jun 01; ():55-9. PubMed ID: 26281127
    [Abstract] [Full Text] [Related]

  • 16. Utilizing increased risk for disease transmission (IRD) kidneys for pediatric renal transplant recipients.
    Hwang CS, Gattineni J, MacConmara M.
    Pediatr Nephrol; 2019 Oct 01; 34(10):1743-1751. PubMed ID: 31243535
    [Abstract] [Full Text] [Related]

  • 17. Successful treatment of donor-derived hepatitis C viral infection in three transplant recipients from a donor at increased risk for bloodborne pathogens.
    Shah AP, Cameron A, Singh P, Frank AM, Fenkel JM.
    Transpl Infect Dis; 2017 Apr 01; 19(2):. PubMed ID: 28060446
    [Abstract] [Full Text] [Related]

  • 18. Mortality and Kidney Transplantation Outcomes Among Hepatitis C Virus-Seropositive Maintenance Dialysis Patients: A Retrospective Cohort Study.
    Sawinski D, Forde KA, Lo Re V, Goldberg DS, Cohen JB, Locke JE, Bloom RD, Brensinger C, Weldon J, Shults J, Reese PP.
    Am J Kidney Dis; 2019 Jun 01; 73(6):815-826. PubMed ID: 30704882
    [Abstract] [Full Text] [Related]

  • 19. Long-term outcomes of liver transplantation in patients with hepatitis C infection are not affected by HCV positivity of a donor.
    Stepanova M, Sayiner M, de Avila L, Younoszai Z, Racila A, Younossi ZM.
    BMC Gastroenterol; 2016 Nov 15; 16(1):137. PubMed ID: 27846801
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.